These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 19101354)

  • 21. An observational study of the effectiveness and safety of intramuscular olanzapine in the treatment of acute agitation in patients with bipolar mania or schizophrenia/schizoaffective disorder.
    Centorrino F; Meyers AL; Ahl J; Cincotta SL; Zun L; Gulliver AH; Kinon BJ; Houston JP
    Hum Psychopharmacol; 2007 Oct; 22(7):455-62. PubMed ID: 17708578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.
    Daniel DG; Currier GW; Zimbroff DL; Allen MH; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
    J Psychiatr Pract; 2007 May; 13(3):170-7. PubMed ID: 17522560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudoakathisia and negative symptoms in schizophrenic subjects.
    Brown KW; White T
    Acta Psychiatr Scand; 1991 Jul; 84(1):107-9. PubMed ID: 1681679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loxapine versus haloperidol parenterally in acute psychosis with agitation. A double-blind study.
    Fruensgaard K; Korsgaard S; Jorgensen H; Jensen K
    Acta Psychiatr Scand; 1977 Oct; 56(4):256-64. PubMed ID: 335787
    [No Abstract]   [Full Text] [Related]  

  • 25. A review of agitation in mental illness: treatment guidelines and current therapies.
    Marder SR
    J Clin Psychiatry; 2006; 67 Suppl 10():13-21. PubMed ID: 16965191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of intranasal haloperidol in an acute Psychiatry Unit: a pilot study on schizophrenic patients with mild-modedate agitation.
    Duñó Ambròs R; Oliva Morera JC; Iglesias-Lepine ML; Palao Vidal D; Monreal Ortiz JAMO; Labad Arias J
    Actas Esp Psiquiatr; 2021 Sep; 49(5):205-209. PubMed ID: 34533203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intramuscular olanzapine in the management of acute agitation.
    Tulloch KJ; Zed PJ
    Ann Pharmacother; 2004 Dec; 38(12):2128-35. PubMed ID: 15522977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Psychomotor agitation, pharmaceutical sedation and psychiatric emergency in psychotic patients].
    Passamar M; Tellier O; Vilamot B
    Encephale; 2011 Dec; 37(6):448-56. PubMed ID: 22137217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation.
    Volavka J; Nolan KA; Kline L; Czobor P; Citrome L; Sheitman B; Lindenmayer JP; McEvoy J; Lieberman JA
    Schizophr Res; 2005 Jul; 76(1):127-9. PubMed ID: 15927808
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
    Ascher-Svanum H; Stensland M; Zhao Z; Kinon BJ
    BMC Psychiatry; 2005 Jan; 5():3. PubMed ID: 15649317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Parenteral Antipsychotics in the Treatment of Agitation and Aggression].
    Utzerath G; Reske D; Gouzoulis-Mayfrank E
    Fortschr Neurol Psychiatr; 2015 Dec; 83(12):665-75. PubMed ID: 26714248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy of aripiprazole for the treatment of schizophrenia: what dose is required?].
    Charpeaud T; Samalin L; Llorca PM
    Encephale; 2014 Feb; 40(1):62-73. PubMed ID: 24445245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A naturalistic evaluation of intramuscular ziprasidone versus intramuscular olanzapine for the management of acute agitation and aggression in children and adolescents.
    Khan SS; Mican LM
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):671-7. PubMed ID: 17201611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A naturalistic study of consecutive agitated emergency department patients treated with intramuscular olanzapine prior to consent.
    Damsa C; Adam E; Lazignac C; Mihai A; DE Gregorio F; Lejeune J; Maris S; Clivaz E; Allen MH
    Am J Psychiatry; 2008 Apr; 165(4):535-6. PubMed ID: 18381919
    [No Abstract]   [Full Text] [Related]  

  • 35. Olanzapine for primary negative symptoms.
    Licht RW
    Am J Psychiatry; 1998 Aug; 155(8):1133-4. PubMed ID: 9699711
    [No Abstract]   [Full Text] [Related]  

  • 36. Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia.
    Brook S
    J Clin Psychiatry; 2003; 64 Suppl 19():13-8. PubMed ID: 14728085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of olanzapine: an overview of pivotal clinical trials.
    Beasley CM; Tollefson GD; Tran PV
    J Clin Psychiatry; 1997; 58 Suppl 10():7-12. PubMed ID: 9265910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olanzapine versus haloperidol in the treatment of agitation in elderly patients with dementia: results of a randomized controlled double-blind trial.
    Verhey FR; Verkaaik M; Lousberg R;
    Dement Geriatr Cogn Disord; 2006; 21(1):1-8. PubMed ID: 16244481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Worsened agitation and confusion in schizophrenia subsequent to high-dose aripiprazole.
    Thone J
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):481-2. PubMed ID: 18070865
    [No Abstract]   [Full Text] [Related]  

  • 40. Evidence for onset of antipsychotic effects within the first 24 hours of treatment.
    Kapur S; Arenovich T; Agid O; Zipursky R; Lindborg S; Jones B
    Am J Psychiatry; 2005 May; 162(5):939-46. PubMed ID: 15863796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.